After a 13 year drought without approval of any new medications to help combat obesity, the American Food and Drug Administration (FDA) approved a new medication called lorcaserin (trade name Belviq) this week.
I was asked to write an editorial with my colleague, professor Arne Astrup, for Medscape Today about this new weight loss...
After a 13 year drought without approval of any new medications to help combat obesity, the American Food and Drug Administration (FDA) approved a new medication called lorcaserin (trade name Belviq) this week.
I was asked to write an editorial with my colleague, professor Arne Astrup, for Medscape Today about this new weight loss medication - you can read the full editorial here.
Dr Sue Pedersen www.drsue.ca © 2012 drsuetalks@gmail.com
Follow me on Twitter for daily tips! @drsuepedersen
